A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A

Background: As a Class A bioterrorism agent, botulinum neurotoxin serotype A (BoNT/A) carries the risk of being used by terrorists to cause mass poisoning. The microneedle (MN) patch has a great potential for application as a novel vaccine delivery method. The aim of this study is to develop a thermally stable, dissolving microneedle patch for the delivery of a recombinant protein vaccine using a recombinant C-terminal heavy chain of BoNT/A (Hc of BoNT/A, AHc) to prevent botulism. Methods: Fish gelatin, a natural non-toxic and bacteriostatic material, was selected as the microneedle matrix for the preparation of the dissolving microneedle vaccine. Subsequently, the mechanical performance, bacteriostatic properties, vaccination effect, and stability of the microneedle patches were evaluated using instruments such as the displacement-force test station and optical coherence tomography (OCT) scanner. Results: Fish gelatin matrix at high concentrations has good bacteriostatic properties, and excellent mechanical performance and vaccination effect, meeting the necessities of a vaccine. In both in vivo and in vitro neutralization experiments, MN vaccines containing different antigen doses achieved the same protective efficacy as subcutaneous vaccinations, protecting mice against 106 LD50 of BoNT/A injected intraperitoneally. Thermal stability analysis of the MN vaccines revealed that the fish gelatin matrix protected the AHc vaccine from protein denaturation even after 7 days of storage at 37 °C and enabled the vaccine patches to maintain good immunogenicity and protective efficacy even after 6 months of storage at room temperature. Conclusion: In this study, we successfully prepared a bacteriostatic MN patch using a fish gelatin matrix that not only has a good vaccination effect, but also obviates the need for a cold chain for the AHc vaccine, providing the possibility of rapid, painless, and large-scale vaccination.

[1]  Mei Shu,et al.  Characterization, antioxidant and antibacterial activities of gelatin film incorporated with protocatechuic acid and its application on beef preservation , 2021 .

[2]  Li Xinyue,et al.  An investigation of a botulism poisoning event in Urumqi, Xinjiang , 2021 .

[3]  B. Mazzolai,et al.  Engineering Microneedle Patches for Improved Penetration: Analysis, Skin Models and Factors Affecting Needle Insertion , 2021, Nano-micro letters.

[4]  S. Al-Nimry,et al.  Cosmetic, Biomedical and Pharmaceutical Applications of Fish Gelatin/Hydrolysates , 2021, Marine drugs.

[5]  P. Estrela,et al.  Hydrogel-Forming Microneedles: Current Advancements and Future Trends. , 2020, Macromolecular bioscience.

[6]  I. Ahmad,et al.  Improving Rate of Gelatin/Carboxymethylcellulose Dissolving Microneedle for Transdermal Drug Delivery , 2020 .

[7]  Yun-zhou Yu,et al.  Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A. , 2020, Vaccine.

[8]  Kyung Ju Lee,et al.  A Practical Guide to the Development of Microneedle Systems - in Clinical Trials or on the Market. , 2020, International journal of pharmaceutics.

[9]  H. Cai,et al.  Microneedle Patch-Mediated Treatment of Bacterial Biofilms. , 2019, ACS applied materials & interfaces.

[10]  J. Irache,et al.  Understanding the basis of transcutaneous vaccine delivery. , 2019, Therapeutic delivery.

[11]  Jung-Hwan Park,et al.  Insertion‐responsive microneedles for rapid intradermal delivery of canine influenza vaccine , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Krasimir Vasilev,et al.  Self-sterilizing antibacterial silver-loaded microneedles. , 2018, Chemical communications.

[13]  Kaushalkumar Dave,et al.  Microneedles in the clinic. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Suzanne R. Kalb,et al.  Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature , 2017, Toxins.

[15]  R. Donnelly,et al.  Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success. , 2016, Current pharmaceutical design.

[16]  M. Prausnitz,et al.  Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches , 2016, Pharmaceutical Research.

[17]  Brian H. Raphael,et al.  Historical and current perspectives on Clostridium botulinum diversity. , 2015, Research in microbiology.

[18]  D. McAllister,et al.  Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature , 2015, Drug Delivery and Translational Research.

[19]  L. Jouneau,et al.  Pig Skin Includes Dendritic Cell Subsets Transcriptomically Related to Human CD1a and CD14 Dendritic Cells Presenting Different Migrating Behaviors and T Cell Activation Capacities , 2014, The Journal of Immunology.

[20]  Yan-jun Yang,et al.  Determinants for the improved thermostability of a mesophilic family 11 xylanase predicted by computational methods , 2014, Biotechnology for Biofuels.

[21]  N. Tas,et al.  Microneedle Characterization Using a Double-Layer Skin Simulant , 2013 .

[22]  Conor O'Mahony,et al.  Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. , 2013, International journal of pharmaceutics.

[23]  Wang Jing-lin.  Advances in research on vaccines and antibodies for defending against botulism , 2013 .

[24]  H. Pei-tang.  Prophylactic and therapeutic medicament against botulinum neurotoxins:research and development progresses , 2012 .

[25]  J. Stockman,et al.  Dissolving polymer microneedle patches for influenza vaccination , 2012 .

[26]  X Q Kong,et al.  Numerical simulation of microneedles' insertion into skin , 2011, Computer methods in biomechanics and biomedical engineering.

[27]  R. Dhaked,et al.  Botulinum toxin: Bioweapon & magic drug , 2010, The Indian journal of medical research.

[28]  Suhkmann Kim,et al.  Enhancement of the thermostability of a recombinant β-agarase, AgaB, from Zobellia galactanivorans by random mutagenesis , 2010, Biotechnology Letters.

[29]  Leonard A. Smith,et al.  Botulism: Cause, Effects, Diagnosis, Clinical and Laboratory Identification, and Treatment Modalities , 2007, Disaster Medicine and Public Health Preparedness.

[30]  S. Yue-jun.  Study on the sebum content and stratum corneum hydration in the normal Chinese population , 2007 .

[31]  Mark R Prausnitz,et al.  Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. , 2004, Journal of biomechanics.

[32]  K. Draget,et al.  Physical behaviour of fish gelatin-κ-carrageenan mixtures , 2004 .

[33]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.